The optimal treatment of STEMI: new pharmacological and device approaches.

M. R. Movahed

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.

Original languageEnglish (US)
Pages (from-to)339-343
Number of pages5
JournalPanminerva medica
Issue number4
StatePublished - Dec 2013

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'The optimal treatment of STEMI: new pharmacological and device approaches.'. Together they form a unique fingerprint.

Cite this